Overview
Dr. Camarena is interested in utilizing novel technology for the advancement of surgical care in trauma and critically ill patients. Dr. Camarena is currently working on targeted therapeutic delivery utilizing stereo-complexed hydrogel microparticles to mediate inflammation and promote tissue regeneration in the setting of traumatic injury. He has additional interest in studying the mechanisms and potential targets for treatment in endotheliopathy in sepsis. He received his B.S. in Neuroscience from the University of Southern California (2013) and M.D. from the University of Chicago Pritzker School of Medicine (2021). He is currently completing his General Surgery residency at Duke and plans to specialize in Trauma and Critical Care.